XML 20 R7.htm IDEA: XBRL DOCUMENT v3.4.0.3
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Dec. 31, 2015
Mar. 31, 2016
Dec. 31, 2015
Mar. 31, 2015
Cash flows from operating activities:            
Net income (loss) $ 23,344 $ 25,646        
Adjustments to reconcile net loss to net cash provided by operating activities:            
Depreciation 4,588 5,306        
Amortization and impairment of intangible assets 1,214 1,093        
Provision for loan and lease losses 21,053 32,970        
Deferred income tax (benefit) expense 3,635 2,060        
Stock-based compensation 1,557 1,457        
Gain on sales of investments, net (8) 0        
Loss on early extinguishment of borrowings (4,217) 0        
Other-than-temporary impairments on debt securities 6,687 156        
Derivative instruments and financial liabilities measured at fair value, gain 153 72        
Loss (gain) on sale of premises and equipment and other assets 0 194        
Net gain on sale of loans held for investment (2,488) (1,689)        
Net amortization of premiums, discounts and deferred loan fees and costs (2,343) (673)        
Originations and purchases of loans held for sale (107,034) (89,425)        
Sales and repayments of loans held for sale 108,615 87,051        
Amortization of broker placement fees 858 1,335        
Net amortization of premium and discounts on investment securities 447 1,269        
(Increase) decrease in accrued interest receivable 3,806 1,953        
Decrease in accrued interest payable 2,257 1,000        
Decrease (increase) in other assets 3,320 8,562        
Increase (decrease) in other liabilities (11,167) 11,007        
Business Combination Bargain Purchase Gain Recognized Amount 0 (13,443)        
Net cash provided by operating activities 54,277 75,513        
Cash flows from investing activities:            
Principal collected on loans 735,801 751,062        
Loans originated and purchased (627,105) (705,621)        
Proceeds from sale of loans held for investment 0 2,230        
Proceeds from sale of repossessed assets 12,375 18,446        
Proceeds from sale of available-for-sale securities 14,990 0        
Purchases of securities available for sale (62,770) (56,429)        
Proceeds from principal repayments and maturities of securities available for sale 62,418 53,596        
Additions to premises and equipment (3,006) (3,027)        
Proceeds from sale of premises and equipment and other assets 0 2,492        
Cash Acquired From Acquisition 0 217,659        
Payments To Acquire Insurance Contracts (1,067) 0        
(Increase) decrease in other equity securities (141) (433)        
Net cash provided by investing activities 131,495 279,975        
Cash flows from financing activities:            
Net decrease in deposits 95,879 (166,924)        
Repurchase of outstanding common stock (259) (236)        
Repayments Of Other Debt (7,025) 0        
Net cash provided (used in) financing activities 88,595 (167,160)        
Net increase in cash and cash equivalents 274,367 188,328        
Cash and cash equivalents at beginning of period 752,458 796,108 $ 796,108      
Cash and cash equivalents at end of period 1,026,825 984,436 752,458      
Cash and cash equivalents include:            
Cash and due from banks       $ 813,732   $ 767,471
Money market instruments       213,093 $ 219,473 216,965
Cash and Cash Equivalents, at Carrying Value, Total $ 752,458 $ 796,108 $ 752,458 $ 1,026,825 $ 752,458 $ 984,436